retatrutide tiktok influencers fuelling parallel market for unlicensed weight-loss drug | Consumer affairs Warning issued over counterfeit weight-loss

Otherwise, serious adverse events were reported in ~6% of participants and were evenly distributed across tirzepatide and placebo groups

According to GoodRx, 88% of patients who still have coverage for GLP-1 agonists will face additional requirements to access them

Week 1 starts with hope

And third, both studies were done specifically in people with prediabetes, who already have disrupted blood sugar regulation

Meal timing around injections deserves consideration

Lower fasting insulin and C-peptide Reduced HOMA2-IR (insulin resistance) Improved lipid profile (triglycerides) Raised adiponectin, lowered leptin Better glucose control Liver Fat Retatrutide reduced liver fat content by as much as 76% for MASLD patients, with the majority of the change occurring during the first 24 weeks